ENTITY
Green Cross Cell

Green Cross Cell (031390 KS)

11
Analysis
Health Care • South Korea
Green Cross Cell Corp is a biotechnology company. The Company develops and commercializes bio-products for immunity cell therapy, and operates autologous lymphocyte, cord blood, and tumor cell bank. Green Cross also tests extreme drug resistance assay (EDR).
more
•10 Oct 2021 04:12

GC Lab Cell Merger: Multi-Staged Arb Setups for Swap Spreads & KOSDAQ 150 Rebalancing on Oct 27

GC Lab Cell merger's cancellation risk has gone as the stock purchase cost was kept below the threshold. This post examines the stock swap arb...

Logo
502 Views
Share
•13 Sep 2021 11:59

Green Cross Merger Got Shareholder Approval (Both Companies): Arb Spread at 5%, I'd Trade It

Green Cross Merger got shareholder approval today from both companies. The current arb spread is at 5%. This post explains why I would arb-trade it...

Logo
421 Views
Share
•25 Aug 2021 14:08

Green Cross Stock Swap: A 5% Spread Is a Rare Opportunity

This post examines the Green Cross stock swap event, which is currently at a spread of 5% two weeks before the appraisal rights exercise period.

Logo
344 Views
Share
•20 Jul 2021 08:47

Green Cross Merger Swap Summary & Arb Spread Status

This merger swap is very similar to the recent case of the GS merger swap. So, we are likely to face a rather juicy swap spread opening probably 2...

Logo
452 Views
Share
•19 Jul 2021 20:43

GC Cell - GC LabCell: Korean Biopharma Merger Trading Tight

South Korean Biopharma companies GC Cell and GC Lab Cell are merging in an all-stock Deal. The companies have a combined market cap of ~US$1.5bn....

Share
x